September 6, 2013Open Access

Plasma Sphingosine-1-Phosphate Is Elevated in Obesity

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

We show that elevations in plasma S1P are a feature of both human and rodent obesity and correlate with metabolic abnormalities such as adiposity and insulin resistance.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Kowalski et al. (Fri,) studied this question.

synapsesocial.com/papers/69dd11aeaa9a964e8d133367 https://doi.org/https://doi.org/10.1371/journal.pone.0072449

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Considerations in the Design of Hyperinsulinemic-Euglycemic Clamps in the Conscious Mouse2006 · 407 citations
2Sphingosine 1-phosphate increases glucose uptake through trans-activation of insulin receptor2009 · 81 citations
3Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate1996 · 1,535 citations
4Promotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-Phosphate2007 · 877 citations
5Mechanism of enhanced insulin sensitivity in athletes. Increased blood flow, muscle glucose transport protein (GLUT-4) concentration, and glycogen synthase activity.1993 · 237 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo